Novo Nordisk Loses Challenge To Medicare Drug Price Talks

By Dan McKay · August 1, 2024, 5:39 PM EDT

Another challenge to a Medicare drug price negotiation program has failed after a New Jersey federal judge ruled once again that the program is voluntary and rejected claims that it violates...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

NOVO NORDISK INC. et al v. BECERRA et al

Case Number

3:23-cv-20814

Court

New Jersey

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

September 29, 2023

Recent Articles By Dan

July 30, 2024
Bad Info Goes Viral: On FDA's Drug Misinformation Proposal
July 30, 2024
Mixed Ruling in NC Knocks Down Rare Abortion Restriction
July 24, 2024
Native Hawaiian Midwives Gain Relief From Licensing Law
July 23, 2024
Dead Or Not Quite: Hospitals Weigh Shared Definition Of DOA
July 23, 2024
Hospital Cites Rare Doctrine In Colo. Trans Care Clash
July 16, 2024
Ex-FDA Head Calls For Congressional Action On Medical AI
July 16, 2024
In Chevron's Fall, Attys See Conflicting Rulings, Circuit Splits
July 09, 2024
Calif. Health Players Back Managed Care Tax Amid Uncertainty
July 02, 2024
Arizona AG Abortion Opinion May Influence Courts, Doctors
July 02, 2024
Whistleblower Or Felon? Texas Doc Faces Rare HIPAA Charge